AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med., s1-30(5), 1950, pp. 677-680
Copyright © 1950 by American Journal of Tropical Medicine

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pijoan, M. J.
Right arrow Articles by Dineen, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pijoan, M. J.
Right arrow Articles by Dineen, J.

Progress in the Treatment of Trachoma with Chloromycetin* (Chloramphenicol),{dagger}

Michel J. Pijoan1, Eugene H. Payne2 AND John Dineen3

The introduction of sulfonamides in the treatment of trachoma (granular conjunctivitis) has resulted in bringing about an amelioration of the disease (1, 2, 3). In general, the treatment consists of the systemic use of the drug rather than local application to the eyes, the course of therapy lasting from ten days to two weeks, allowing a rest period, and then repeating the process once again. Improvement may be dramatic or gradual or, in some cases, requiring several months before the effects are noticeable. These studies have been confirmed experimentally in baboons infected with trachoma (4). Under carefully controlled conditions the sulfonamides have been generally successful for the treatment of this disease. The precise mechanism of how these agents act, whether as a structural analog of para-amino benzoic acid, and substituting for this necessary bacterial vitamin, is unknown with respect to trachoma. It must also be further noted that trachoma is a protean disease varying in its manifestation and degree of infectiousness.


* Registered Trademark.


{dagger} This paper is based on a report given at the annual meeting of the American Society of Tropical Medicine, Memphis, Tennessee, November 5, 1949.


1 Chief Internal Medicine, Navajo Medical Center, Fort Defiance, Arizona.


2 From the Department of Clinical Investigation, Parke, Davis and Company, Detroit, Michigan.


3 Ophthalmologist, Consultant to the Navajo Medical Center, Fort Defiance and Gallup, New Mexico.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1950 by the American Society of Tropical Medicine and Hygiene.